Events, Publications, & News
Meetings & Workshops
Events by Date
1998 & earlier
| Opens resource in a 2nd browser window.
10th International Conference on Intelligent Systems for Molecular Biology
[ISMB] (Edmonton, Canada) August 3-7, 2002. The ISMB 2002 Conference provides a general forum for disseminating the latest developments in bioinformatics. It is a multidisciplinary conference that brings together scientists from molecular biology, medicine, computer science, mathematics and statistics. Its scope includes the development and application of advanced computational methods for biological problems at the levels of sequences, cells, organs, and organisms.
2nd ASM & TIGR Conference on Microbial Genomes.
[ASM & TIGR] (Las Vegas, Nevada) February 10-13, 2002. This conference will continue the successful collaboration of ASM and TIGR on the first ASM & TIGR Conference on Microbial Genomes. It will combine the scientific excellence of the two sponsoring organizations' previous meetings on the topic--ASM's Genomes 2000 and 1997 & 1998 Small Genomes Conferences with TIGR's annual Microbial Genomes Conferences.
6th ASM Conference on Candida and Candidiasis
[ASM] (Tampa, Florida) January 13-17, 2002. The goals for this current conference are to bring together researchers working on all aspects of the biology of C. albicans for a forum to discuss the present state of their research.
6th ASM Conference on Streptococcal Genetics
[ASM] (Asheville, North Carolina) April 14-17, 2002. "The major goal of the conference is to provide a setting for exchange of the most current knowledge regarding the genetics and molecular biology of streptococci, enterococci, and lactococci. The emphasis of all presentations will be the genetic analysis of fundamental biological functions, or the description of new genetic tools useful for the study of such functions."
9th ASM Undergraduate Microbiology Education Conference
[ASM] (Salt Lake City, UT) May 17-19, 2002. The annual task-oriented conference for undergraduate microbiology faculty.
AAAS Annual Meeting
[AAAS] (Boston, MA) February 14-19, 2002. The AAAS Annual Meeting offers a unique, exciting, interdisciplinary blend of more than 130 symposia, plenary and topical lectures, Genome and Nanotechnology seminars, poster presentations, Career Workshops and a Career Fair, and an Exhibit Hall.
Advances in Genome Biology and Technology
[GCORP] (Marco Island, FL) February 6-9, 2002. In 2002, AGBT will feature the expanding impact of genomic data on biological discovery across a wide variety of systems, including plants, microbes, and animals. Plenary sessions will highlight human genetics, mouse genetics, gene expression, and proteomic characterization.
Beyond Genome: Information for the Computational Age
[Cambridge Healthtech Institute] (San Diego, CA) June 2-7, 2002. Beyond Genome is a weeklong event covering a number of computational tools used in the analysis and correlation of genomic data.
(Toronto, Ontario, Canada) June 9-12, 2002. The BIO 2002 Internationl Biotechnology Convention and Exhibition is the world's largetst biotechnology event.
Bioinformatics & Genomics Research
[Cambridge Healthtech Institute] (San Diego, CA) June 4-5, 2002. The Bioinformatics & Genomics Research conference will focus on the tools needed to systematically link different types of datasets, and annotate the experimental data with clinical information.
Top of Page
Bioinformatics Methods and Techniques
[Stanford Center for Professional Development] (Stanford, CA) June 18-20, 2002. This three-day, intensive survey course will explain the extraordinarily broad scope of bioinformatics, discuss the theory and practice of computational methods, and provide insight that will help attendees gain a more sophisticated understanding of the applicability and limitations of those approaches.
[Biotechfind.com] (Geneva, Switzerland) September 23-25, 2002. BioNetwork 2002 is the premier bio-partnering event for biotech and
pharma business development and licensing executives worldwide. With a
unique structure of industry case studies, roundtable discussion groups
and one-to-one meetings, attendees will hear the partnering strategies
of big pharma through to mid-sized biotechs.
Biotechnology Havana 2002
[Center for Genetic Engineering and Biotechnology] (Havana, Cuba) November 24-29, 2002. In the framework of the series of annual meetings Biotecnología Habana, the 2002 edition will be devoted to the application of Biotech to plants and animals: The best place to be in 2002 to see, hear and discuss the latest in Animal and Plant Biotechnology. The five-day conference features some of the world's top researchers and specialists, key business and investment leaders.
[The Center for Business Intelligence] (Boston, MA) May 30-31, 2002. The Center for Business Intelligence’s BioVenture Forum allows biotech companies to gain access to existing capital by showcasing technologies and exploring unique financial vehicles. The conference offers specific case studies of biotech companies that have recently acquired funding from venture capital companies, as well as show VC companies what to look for when investing in Biotech companies.
Cell-Based Microarrays and High-Content Screening
(San Diego, CA) March 18-22, 2002. This conference will cover applications for various cell-based assay technologies, including high content cellular assays and emerging miniaturized platforms for automated electrophysiology and high throughput screening.
Chemical Genomics Strategies toward Concurrent Target Validation & Lead Discovery Optimization
[IBC] (Philadelphia, PA) May 30-31, 2002. This inaugural conference will not only provide an up-to-date look at the latest tools, but also actual case studies of chemical genomics applications.
[Cambridge Healthtech Institute] (Philadelphia, PA) May 6-8,2002. This conference will showcase cheminformatic tools for storage, design and mining of chemical databases/information and present case examples of its success in lead identification and optimization.
Chips To Hits 2002
[IBC] (Philadelphia, PA) October 28 - November 1, 2002. The event brings together industry and academia to address technology and application of microarrays, protein arrays, microfluidics, sample prep, data/imaging analysis and emerging technologies in the field.
Drug Discovery Informatics
[ACI] (Scottsdale, AZ) January 23-25, 2002. Senior level conference with case studies covering why integrating Bio&Chem Informatics is vital to streamlining the drug discovery process.
Emerging Microarray Technologies and Application
(San Diego, CA) March 18-22, 2002. This is the first meeting to recognize and combine the most promising areas of scientific advancements, therapeutic applications, and commercial developments in microtechnology. This five-day meeting features the latest research in the following three areas: Protein Microarrays, Cell-Based Microarrays and High-Content Screening, and Microarrays for Diagnostics.
Top of Page
[IBC] (San Francisco, CA) March 4-6, 2002. IBC's World Congress on Enzyme Technologies is driven by this intersection of biology and engineering, and provides a showcase for both industry scientists and executives who want to identify and discuss the latest trends, technologies, techniques and products in this growing industry.
Exploiting Molecular Diversity
[Cambridge Healthtech Institute] (San Diego, CA) February 11-12, 2002. Those interested in learning how to develop more effective libraries faster and cheaper, as well as learning from case studies where informed design in conjunction with novel assay development has been successful, are invited to attend this meeting.
First Annual TIGR Functional Genomics Meeting
[TIGR] (Tampa, Florida) January 17-20, 2002. The First Annual TIGR Functional Genomics Meeting will provide a venue for discussing topics such as recent results from microarray analysis, the tools being developed for analyzing the data they produce, and applications to understanding fundamental questions in biology.
Fluorescence Methods in Drug Discovery: Principles and Applications
[IBC] (San Diego, CA) March 7-8, 2002. This 2-day intense course gives you a basic orientation to fluorometric assays, both in fundamental concepts and in applications
Fluorescence Methods in Drug Discovery: Principles and Applications
[IBC] (Philadelphia, PA) April 8-9, 2002. This 2-day intense course gives you a basic orientation to fluorometric assays, both in fundamental concepts and in applications.
Fluorescence Methods in Drug Discovery: Principles and Applications
[IBC] (San Francisco, CA) April 29-30, 2002. This 2-day intense course gives you a basic orientation to fluorometric assays, both in fundamental concepts and in applications
Gene Functional Analysis
[Cambridge Healthtech Institute] (Santa Clara, CA) February 28 - March 1, 2002. Various approaches to modeling pathways will be addressed, along with the technical hurdles and accomplishments deployed towards that goal.
[Cambridge Healthtech Institute] (San Diego, CA) February 11-12, 2002. This meeting will examine all known approaches to quantifying genes, as well as begin to consider how quantification of proteins might clarify or confuse our current picture of biology.
Genome Sequencing and Analysis Conference
[TIGR] (Boston, MA) October 2-5, 2002. Attendees from around the world will gather to discuss recent advances within the field of genomics. International experts from academia, government and the private sector
will be represented during GSAC's plenary and concurrent symposia. These sessions will highlight topics such as RNA interference, advances
in genomes of multicellular and single cell organisms, microarray data analysis, evolution of genomes and genome structures.
[Cambridge Healhtech Institute] (Santa Clara, CA) February 23-March 1, 2002. "Cambridge Healthtech Institute's Genome Tri-Conference is the premier industry event for all players in the genomics field. Kicking off the Tri-Conference is Genomic Partnering, providing a platform for early-stage companies to present cutting-edge genomic technologies. The core conference, Human Genome Discovery, highlights important advances in the rapidly developing genomics area which will revolutionize the field of medicine. Rounding out the week is coverage of developments in the increasingly important field of Gene Functional Analysis."
Top of Page
[Cambridge Healthtech Institute] (Santa Clara, CA) February 23-24, 2002. This platform will provide a platform for early-stage companies to present cutting-edge genomic technologies.
High Performance Computing - CANCELLED
[Cambridge Healthtech Institute] (La Jolla, California) January 14-15, 2002. This meeting seeks to cover issues in strategic applications for genomics and proteomics for biotech, pharma, software, and
hardware engineers, for application specialists, and for anyone who envisions the marriage of supercomputers and the life sciences.
High-Throughput Organic Synthesis
[Cambridge Healthtech Institute] (San Diego, CA) February 13-15, 2002. This conference will highlight recent novel chemistries and reaction strategies, as well as optimization of reactions for library synthesis.
Human Genome Discovery
[Cambridge Healthtech Institute] (Santa Clara, CA) February 25-27, 2002. This conference will explore the world of information technology that is impacting genomics and the life-science industry as a whole, as well as the latest efforts to create operating systems for biology.
Human Proteome Project
[Human Proteome Organization] (San Diego, CA) January 9-11, 2002. The reason for creating HUPO is to assist in increasing the awareness of this discipline of science across society, particularly with regard to the Human Proteome Project, and to engender a broader understanding of the importance of proteomics and the opportunities it offers in the diagnosis, prognosis, and therapy of disease.
Identifying & Validating Drug Targets through Genomics
[Strategic Research Institute] (Princeton, NJ) March 11-12, 2002. Topics to be addressed include: SNP Analysis & Genome Scans, Use of Key Animal Models, In-Vivo Functional Genomics, Antisense Functional Genomics, Engineered Transcription Factors, Ultra-Large HTP Libraries, DNA Microarrays, and Genomic Variation Information & Bioinformatics
Immunity to Bacterial, Viral, and Protozoal Pathogens
[ASM] (Savannah, Georgia) March 20-24, 2002. The ASM conference on Immunity to Bacterial, Viral, and Protozoal Pathogens.
Impact of Genomics on Medicine
[CHI] (Munich, Germany) May 13-14, 2002. This meeting will highlight the importance of a genomic approach to drug development and estimate the actual benefit of integrating genomic data into clinical practice.
In Silico Biology
[Cambridge Healthtech Institute] (San Diego, CA) June 2-3, 2002. This conference will showcase examples and applications of computational modeling of cells, tissues, and disease.
Integrated Bioinformatics: High-Throughput Interpretation of Pathways and Biology
(Zurich, Switzerland) January 14-16, 2002. Topic areas include: Statistical Analysis of Microarray data, Computational Challenges in Genomic and Proteomic Data, Engineering Protein Networks, Pathway Informatics, and Linking Gene Expression with Clinical Outcomes.
Top of Page
International Conference on Magnetic Resonance in Biological Systems
[ICMRBS] (Toronto, Ontario, Canada) August 25 - 30, 2002, all technical sessions, posters, and exhibits will be at the Fairmont Royal York Hotel, 100 Front Street West, Toronto, Ontario, Canada.
Lab-on-a-Chip and Microarrays
[Cambridge Healthtech Institute] (Zurich, Switzerland) January 14-16, 2002. Innovations in technology and the resulting applications of lab-on-a-chip and microarray technologies re the focus of this conference. Topic areas includes: New insights in biology through gene expression studies, exploitation of gene expression know-how, Lab-on-a-Chip and Microarray applications in the diagnostic field, Lab-on-a-Chip in Action: Point of need testing, and Dissecting signaling pathway signatures from microarray data.
Microarrays for Diagnostics
(San Diego, CA) March 18-22, 2002. Leading academic and industry experts will explore the latest in technology, applications, regulatory challenges, as well as alternative technologies for diagnostics.
Microfluidics 2002 Revolutionizing Drug Discovery, Diagnostics & Therapeutics
[IBC] (San Francisco, CA) September 18-20, 2002. The beauty and inspiration of Microfluidics lie in its ability to miniaturize, integrate and automate the work of biologists, chemists and engineers. Just as integrated circuits revolutionized the electronics industry in the 1960s, Microfluidics is said to transform biochemical analysis and high throughput screening, creating dramatic breakthroughs in drug discovery, diagnostics and proteomics.
Model Organisms for Drug Discovery
[IBC] (Boston, MA) August 8-9, 2002. Model organisms are finding a growing role in identifying and validating targets, in screening for lead compounds and in drug profiling. This conference focuses on the uses of model organisms to advance novel chemical entity discovery.
Molecular Analysis for Research and Diagnostics
[Cambridge Healthtech Institute] (San Diego, CA) February 13-14, 2002. The growing momentum of genomics and molecular analysis has enormous promise for numerous drug research applications as well as for diagnostics.
Molecular Diagnostics Meets Therapeutics
[IBC] (Boston, MA) June 4-7, 2002. With the increasing integration of molecular diagnostics and therapeutics, many traditionally separate biotechnology and pharmaceutical companies are coming together to identify genes and proteins; understand the pathways involved in the causes of diseases; and finally to develop drugs that are directly related to these causes.
Molecular Diagnostics Meets Therapeutics
[IBC] (Boston, MA) June 4-7, 2002. Molecular Diagnostics Meets Therapeutics is a first in the industry to take a closer look at the intersection of the two, and the strategies, technologies, research developments and examples that mark the future trends in this direction.
O'Reilly Bioinformatics Technology Conference
[O'Reilly & Associates] (La Paloma Resort, Tucson, Arizona) January 28-31, 2002. A Bioinformatics Technology Conference that will explore the engineering and tool-building aspects of bioinformatics.
Outpartnering and Outsourcing Drug Discovery
[IBC] (Princeton, NJ) April 29 - May 1, 2002. Knowing when (and HOW!) to Integrate External Technologies and Services for Faster Drug Discovery. Learn how top Pharmaceutical and Biotech companies are keeping their competitive edge by integrating external technologies, drug targets and novel compounds with innovative strategies to shorten the time from Drug Discovery to Chemical Development.
Top of Page
Pacific Symposium on Biocomputing 2002
[DOE, NLM/NIH, Partek, Compaq, and the International Society for Computational Biology] (Honolulu, HI) January 3-7, 2002. An annual "international multidisciplinary conference for the presentation and discussion of current research in the theory and application of computational methods in problems of biological significance."
[IBC Drug Discovery Series] (San Francisco, CA) January 23-25, 2002. This conference will cover Consumer Empowerment/Public Policy in Healthcare Decisions, Implementation and Application of Personalized Medicine, Investment Opportunities, Creative Partnering/Deal Making, State-of-the-Art Technologies, and Genetic Patenting Perspectives.
Pharmacogenomics & SNPs
[Strategic Research Institute] (Newark, New Jersey) January 28-29, 2002. The conference is organized into four sections: SNPs & Disease: The Future of Medicine, New Drug Targets: SNP Identification in Disease-Causing Genes, Core Technologies for SNP Discovery & Analysis, and Case Studies: Applications of Pharmacogenomic Technologies in Drug Development.
[CHI] (Munich, Germany) May 15-16, 2002. Coding variation directly impacts how the body handles drugs. What is significant is the extent to which this information can be sought out and used in rational drug design and delivery. As the jury deliberates, evidence accumulates to show that the market will be the final arbiter. North America came out ahead in the race to map the human genome, but can Europe take the lead by implementing this information faster to elucidate disease etiology and protein function, and to improve the drug discovery development process?
Pharmacokinetics in Clinical Research and Drug Product Development
[IBC] (San Diego, CA) March 7-8, 2002. Course includes basic principles, significance to dosing schedules and drug response, and animal, human, and patient factors critical to the extrapolation from In vitro and animal studies to patient response problems
Pharmacokinetics in PRE-Clinical Research and Drug Product Development
[IBC] (San Francisco, CA) April 29-30, 2002. Course includes basic principles, significance to dosing schedules and drug response, and animal, human, and patient factors critical to the extrapolation from In vitro and animal studies to patient response problems.
Plant, Animal and Microbe X Genomes Conference
[Scherago International] (San Diego, CA) January 12 - 16, 2002. A large international annual meeting that focuses on applied plant and animal genomics.
[IBC] (San Francisco, CA) June 24-26, 2002. Biology has entered a new era. "The biggest revolutions in biology are emerging from disciplines not originally considered biological: from engineering, technology and computer science," said Dr. Shankar Subramaniam of the University of San Deigo. This, is the challenge and transformation of the new dogma of science.
[ASM] (Quebec City, Quebec, Canada) July 10-14, 2002. "
The goal of this meeting is to bring together investigators interested in prokaryotic development and biological phenomena related to development. Topics will include differential gene expression, positional information, checkpoints, cell cycle control, cell-cell signaling, motility, chromosome dynamics, pattern formation, organelle synthesis, morphogenesis, multicellularity, and biological rhythms."
[Cambridge Healthtech Institute] (San Diego, California) January 7-8, 2002. Numerous technical obstacles, such as optimizing protein immobilization or selection of protein-binding ligands, strategies for extending the limits of detection, and novel applications of this exciting technology, are among the issues that will be discussed in detail during this conference
Top of Page
[Cambridge Healthtech Institute] (San Diego, California) January 7-8, 2002. This conference will explore the newest data and technologies relating to the expression and characterization of proteins for biological understanding and therapeutics.
Protein Informatics From Databases to Prediction
[Cambridge Healthtech Institute] (San Diego, California) January 13-14, 2003. Extracting the most value from proteomic data comes from being able to better understand and model biology, pathways, and targets to facilitate diagnostic and therapeutic development. CHI's Protein Informatics conference will provide in-depth coverage of the new computational methods and in silico tools necessary to deal with the flood of proteomic data.
The Protein Information Week
[Cambridge Healthtech Institute] (San Diego, California) January 7-11, 2002. Events include a Protein Arrays meeting, January 7-8. The conference runs concurrently with the Fifth Annual Protein Expression meeting on January 7-8. The final leg is the Second Annual Human Proteome Project, Januay 9-11, 2002.
[IBC] (Boston, MA) September 9-10, 2002. Target Validation, Drug discovery and Clinical Development of Kinase Therapeutics. Attend IBC's 2nd Protein Kinases conference and you will come away with a greater understanding of how pharmaceutical companies are actively developing kinase inhibitors that are implicated in various disease states.
[March 18-19, 2002.] (San Diego, CA) This conference will cover how proteome chips are being used by for global analysis of protein activities, how Oxford Glycosciences utilizes protein chip assays in their proteomics projects, and the latest application of protein arrays including: Protein profiling using antibody microarrays and how cell microarrays can be used as protein microarrays.
[Cambridge Healthtech Institute] (San Diego, CA) June 6-7, 2002. Proteomics is being held with the 11th Annual Bioinformatics and 4th Annual In Silico Biology as part of CHI's BEYOND GENOME meeting.
Proteomics Delivering New Routes to Drug Discovery
[IBC] (Philadelphia, PA) May 6-9, 2002. IBC's Annual Proteomics 2002 is the premier event designed to address the critical elements that are driving this field towards drugable targets. This event gives you expert views on the latest tools, techniques and technologies impacting Proteomics analysis, discovery, and integration. This conference delivers cutting-edge presentations, posters, and technology workshops to educate and stimulate discussion on various important topics.
ScreenTech Screening for Success
[IBC] (San Diego, CA) March 4-6, 2002. A conference that shows how to succeed in developing new drug candidates through high-throughput screening and miniaturized technologies.
Superbugs and Superdrugs
[SMi Group] (The Hatton, London) March 6-7, 2002. SMi's Superbugs and Superdrugs conference offers you a top level forum to discuss issues such as the market structure, drug discovery, new technology, commercial and legal issues. The various anti-infective areas will also be covered in detail; antiviral, antifungal and antibacterial therapies.
TIDES 2002: Oligonucleotide and Peptide Technology Conferences
[IBC] (Las Vegas, NV) May 6-8, 2002. Hear all about the planning for FDA approval of G3139 production. Discuss scale-up issues, production progress and the effect T-20 has had on raw material markets.
Top of Page
TRANSCRIPTOME 2002: From Functional Genomics to Systems Biology
[TIGR] (Seattle, Washington) March 10-13, 2002. This year's meeting will attempt to highlight the basic mechanisms by which cells mediate their growth, function, and metabolism, to examine tools and techniques for exploring gene expression, and to look to future applications.